Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses by Lassi Luomala, Juhana Rautiola, Petrus Järvinen, Tuomas Mirtti, Harry Nisén

Get full text

The tumor and plasma cytokine profiles of renal cell carcinoma patients by Moon Hee Lee, Essi Laajala, Anna Kreutzman, Petrus Järvinen, Harry Nísen, Tuomas Mirtti, Maija Hollmén, Satu Mustjoki

Get full text

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma by Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Satu Mustjoki, Anna Kreutzman

Get full text

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma by Lassi Luomala, Kalle Mattila, Paula Vainio, Harry Nisén, Teijo Pellinen, Jouni Lohi, Teemu D. Laajala, Petrus Järvinen, Anna‐Riina Koskenniemi, Panu Jaakkola, Tuomas Mirtti

Get full text

Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASP by Rim Bouslama, Vincent Dumont, Sonja Lindfors, Lassi Paavolainen, Jukka Tienari, Harry Nisen, Tuomas Mirtti, Moin A. Saleem, Daniel Gordin, Per-Henrik Groop, Shiro Suetsugu, Sanna Lehtonen

Get full text

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma by Kalle E. Mattila, Teemu D. Laajala, Sara V. Tornberg, Tuomas P. Kilpeläinen, Paula Vainio, Otto Ettala, Peter J. Boström, Harry Nisen, Laura L. Elo, Panu M. Jaakkola

Get full text

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition by Victor Cervera-Carrascon, Dafne C.A. Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki

Get full text

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vi... by Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm, Moon Hee Lee

Get full text